Our results showed the upregulation of several types of membrane transporters, including drug resistance drivers, such as ABCB1 and ABCG2, in combination with SLC transporters, voltage-gated channels, and GPRs, revealing that EVs may carry a powerful setup to induce drug resistance with multiple approaches in adjacent or distant cancer cells. The gene discussed is ABCG2; the disease is cancer.